Eficácia do formoterol na reversão imediata do broncoespasmo Efficacy of inhaled formoterol in reversing bronchoconstriction

Eficácia do formoterol na reversão imediata do broncoespasmo Efficacy of inhaled formoterol in reversing bronchoconstriction

OBJETIVO: Avaliar efetividade e rapidez de ação do formoterol liberado através de inalador para pó seco na reversão de broncoespasmo induzido pela metacolina. MÉTODOS: Avaliaram-se prospectivamente 84 pacientes com queda do volume expiratório forçado no primeiro segundo 20% após inalação de metacoli...

Full description

Bibliographic Details
Main Authors:	Adalberto Sperb Rubin, Christiano Perin, Liliana Pelegrin, Juliana Cardozo Fernandes, Luiz Carlos Corrêa da Silva
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Pneumologia e Tisiologia 2006-06-01
Series:	Jornal Brasileiro de Pneumologia
Subjects:	Asma Formoterol Fenoterol Terapia inalatória Broncodilatação Metacolina Asthma Inhalation therapy Bronchodilation Methacoline
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132006000300005

Similar Items

Comparison of Rapid Bronchodilatory Effects of Salmeterol and Formoterol in Patients with Moderate to Severe Asthma
by: Ebrahim Salehifar, et al.
Published: (2015-10-01)

New combinations in the treatment of COPD: rationale for aclidinium–formoterol
by: Incorvaia C, et al.
Published: (2016-02-01)

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
by: Tashkin DP
Published: (2020-11-01)

Efecto broncodilatador de fenoterol y salbutamol asociados a un corticoide en niños con crisis de asma.
by: Raúl Huaman, et al.
Published: (1996-01-01)

Dos esquemas terapéuticos en el manejo de crisis asmática en niños.
by: José Velasco, et al.
Published: (1997-01-01)

Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroids
by: Holownia A, et al.
Published: (2009-12-01)

Comparison of the effectiveness and safety of formoterol versus salmeterol in the treatment of patients with asthma: A systematic review and meta-analysis
by: Ashraf Velayati, et al.
Published: (2015-01-01)

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
by: D'Urzo AD, et al.
Published: (2019-02-01)

Cost-effectiveness analysis of budesonide/formoterol (Symbicort(R)) as needed for mild asthma in Malaysia
by: Gopal, VR, et al.
Published: (2021)

Protective effects of different doses of inhaled fenoterol on methacholine-induced bronchoconstriction in asthmatic children
by: Irma Douglas Gomez, et al.

Fenoterol e salbutamol via inalatória em cães: aspectos clínico, hemogasométrico e eletrocardiográfico
by: R.M. Viel, et al.
Published: (2012-02-01)

Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials
by: Jinping Zheng, et al.
Published: (2020-03-01)

Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide–formoterol treatment
by: Wang C, et al.
Published: (2017-12-01)

Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
by: Arun Jenish J, et al.
Published: (2012-03-01)

Fenoterol e Salbutamol via inalatória em cães: aspectos clínico, laboratorial e eletrocardiográfico
by: Viel, Rosilene Martins
Published: (2016)

Fenoterol e Salbutamol via inalatória em cães: aspectos clínico, laboratorial e eletrocardiográfico
by: Viel, Rosilene Martins
Published: (2016)

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
by: Matera MG, et al.
Published: (2016-01-01)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
by: Mantero M, et al.
Published: (2018-07-01)

Efeito do salbutamol liberado através de inalador de pó seco sobre o broncoespasmo induzido por metacolina Effects of salbutamol delivered by dry-powder inhaler on methacholine-induced bronchoconstriction
by: Adalberto Sperb Rubin, et al.
Published: (2004-06-01)

12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review
by: A. A. Vizel, et al.
Published: (2018-10-01)

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
by: Andreas S, et al.
Published: (2020-08-01)

Some aspects of application of the combination of formoterol and budesonide: what is changed?
by: A. A. Vizel, et al.
Published: (2019-12-01)

Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease
by: Ashfaq Hasan, et al.
Published: (2021-01-01)

Filme de quitosana para uso em sistema de liberação controlada de fumarato de formoterol.
by: GUEDES, Dayse de Lourdes Madruga Espínola.
Published: (2014)

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD
by: Watz H, et al.
Published: (2017-08-01)

The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
by: Miravitlles M, et al.
Published: (2016-08-01)

Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids
by: Maarten van den Berge, et al.
Published: (2021-07-01)

Avaliação da resposta broncodilatadora imediata ao formoterol em doença pulmonar obstrutiva crônica (dpoc) com pouca reversibilidade
by: Souza, Fábio José Fabrício de Barros
Published: (2010)

Avaliação da resposta broncodilatadora imediata ao formoterol em doença pulmonar obstrutiva crônica (dpoc) com pouca reversibilidade
by: Souza, Fábio José Fabrício de Barros
Published: (2010)

Avaliação da resposta broncodilatadora imediata ao formoterol em doença pulmonar obstrutiva crônica (dpoc) com pouca reversibilidade
by: Souza, Fábio José Fabrício de Barros
Published: (2010)

In vitro transdermal permeation of fenoterol hydrobromide
by: Ahmed H. Elshafeey, et al.
Published: (2012-04-01)

In Vivo Calibration Methods of SPME and Application to Pharmacokinetic Studies
by: Yeung, Chung Yan
Published: (2009)

In Vivo Calibration Methods of SPME and Application to Pharmacokinetic Studies
by: Yeung, Chung Yan
Published: (2009)

Extrafine combination beclomethasone dipropionate/ formoterol therapy in obstructive lung diseases
by: I. N. Trofimenko, et al.
Published: (2020-08-01)

Differential effects of formoterol on thrombin- and PDGF-induced proliferation of human pulmonary arterial vascular smooth muscle cells
by: Goncharova Elena A, et al.
Published: (2012-11-01)

The value of the medicine fenoterol + ipratropium bromide in the treatment of exacerbations of bronchial asthma and chronic obstructive pulmonary disease
by: О. A. Tsvetkova, et al.
Published: (2020-11-01)

Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
by: Taisuke Akamatsu, et al.
Published: (2012-01-01)

Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma
by: Sasikala Kumaravel, et al.
Published: (2014-01-01)

A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease
by: Omar Usmani, et al.
Published: (2021-10-01)

Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis
by: Tang B, et al.
Published: (2019-04-01)